Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyowa Kirin
Biotech
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug
Kyowa is pledging up to $1.1 billion in milestones to split the U.S. profits of Kura's oral leukemia treatment as well as to secure global rights.
James Waldron
Nov 21, 2024 9:35am
Biogen boosts C-suite with BMS vet—Chutes & Ladders
Nov 1, 2024 8:30am
Boehringer ends week with 3rd deal, this time with Kyowa Kirin
Jan 5, 2024 10:34am
Orchard lands $387M Kyowa buyout as gene therapy nears approval
Oct 5, 2023 9:20am
Guth takes reins of Bayer’s US operations—Chutes & Ladders
Jun 23, 2023 9:30am
2 more biotechs report pipeline, partnership changes
May 12, 2023 11:15am
